A new study by UCLA scientists shows that enhancers, snippets of DNA that contribute to gene regulation, fall into the same “insulated neighborhoods” or chromatin loops as the target gene and other gene-specific regulatory elements.
14-Dec-2018 10:05 AM EST Add to Favorites
Two studies have linked DNA changes to their molecular effects in the brain, revealing new mechanisms for psychiatric diseases. The findings provide a roadmap for developing a new generation of therapies for conditions like autism, schizophrenia and...
12-Dec-2018 6:00 PM EST Add to Favorites
15 percent of babies exposed to Zika before birth had severe abnormalities in first 18 months of life
By age 12 to 18 months, 6.25% of children exposed to Zika during their mothers’ pregnancies had eye abnormalities, 12.2% had hearing problems, and 11.7% had severe delays in language, motor skills and/or cognitive function. In all, 14.5% had at...
5-Dec-2018 8:05 PM EST Add to Favorites
Many people who are diagnosed with cancer will undergo some type of surgery to treat their disease — almost 95 percent of people with early-diagnosed breast cancer will require surgery and it’s often the first line of treatment for people with...
10-Dec-2018 1:05 PM EST Add to Favorites
Few governments make pre-primary education available on a tuition-free basis for two or more years, according to a new study from the WORLD Policy Analysis Center.
4-Dec-2018 4:30 PM EST Add to Favorites
A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia — an important step on the path toward developing therapies that could slow or halt the course of the disease. The findings appear...
3-Dec-2018 9:00 AM EST Add to Favorites
Opioid use in Mexico has been low, but national and international factors are converging and a threat of increased drug and addiction rates exists. Many of these factors may have originated in the U.S., making this a potential joint U.S.-Mexico...
27-Nov-2018 8:05 PM EST Add to Favorites
UCLA researchers have found that commonly used hormone therapies for women diagnosed with breast cancer do not appear to cause significant cognitive dysfunction following the treatment.
28-Nov-2018 2:05 PM EST Add to Favorites
see all news
UCLA health expert available to comment on FDA approval of targeted cancer therapy, larotrectinib, for patients with a wide variety of cancers.
27-Nov-2018 2:40 AM EST
5-Nov-2018 6:05 PM EST
5-Nov-2018 6:05 PM EST
UCLA oncologist Dr. Parvin Peddi, assistant clinical professor in medicine and member of the UCLA Jonsson Comprehensive Cancer Center, discusses four myths regarding the most common cancer in U.S. women.
2-Oct-2018 11:05 AM EDT
This Prostate Cancer Awareness Week, urologist shares three things patients are surprised to learn
19-Sep-2018 10:05 AM EDT
19-Sep-2018 9:05 AM EDT
Although ovarian cancer is often considered a relatively rare cancer – accounting for only about 3 percent of all cancers in women – it causes more deaths than any other cancer of the female reproductive system. In September, also known as...
21-Aug-2018 3:05 PM EDT
25-Jun-2018 11:05 AM EDTsee all experts